SciELO - Scientific Electronic Library Online

 
vol.34 issue3Initial experience with zero or near zero-fluoroscopy to perform catheter ablation of supraventricular tachycardias in a private practice setting author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Cardiovascular and metabolic science

On-line version ISSN 2954-3835Print version ISSN 2683-2828

Abstract

WIBAWA, Kevin et al. Cardiac arrhythmia among hospitalized COVID-19 patients at Gunung Jati General Hospital, Indonesia. Cardiovasc. metab. sci [online]. 2023, vol.34, n.3, pp.94-106.  Epub Apr 15, 2024. ISSN 2954-3835.  https://doi.org/10.35366/112758.

Introduction:

arrhythmia is one of the most common extrapulmonary complications of coronavirus 2019 (COVID-19).

Objectives:

this study aimed to assess the outcomes of hospitalized COVID-19 patients with and without arrhythmia from asymptomatic to life-threatening disease severity and the predictors of the in-hospital outcomes.

Material and methods:

a total of 257 patients with confirmed COVID-19 who had at least one electrocardiogram recording from April 01 to December 31, 2021, were enrolled in this cross-sectional study.

Results:

arrhythmia occurred in 36.6% of patients. The mean age of patients with arrhythmia was 52.48 ± 13.936 years, with a male preponderance (57.4%). The most common arrhythmia was sinus tachycardia (69.1%). Pre-existing atrial fibrillation (AF) and new-onset AF occurred in 10.6% and 2.1% of patients, respectively. Total atrioventricular block occurred in 2.1% of patients. Heart failure (20.2%), previous arrhythmia (10.6%), hypertension (46.8%), diabetes mellitus (DM) (42.6%), and chronic kidney disease (55.3%) were more prevalent in patients with arrhythmia. Patients with arrhythmia had a significantly higher need for Intensive Care Unit (ICU) (50%), need for intubation and mechanical ventilation (MV) (7.4%), hypotension requiring vasopressor (16%), and in-hospital mortality (44.7%) compared to patients without arrhythmia. After multivariate analysis, DM was associated with a higher need for ICU, hypotension requiring vasopressor, and in-hospital mortality. History of stroke/transient ischemic attack (TIA) and thrombocytopenia during admission was associated with a higher need for intubation and MV.

Conclusions:

the in-hospital outcomes in patients with COVID-19 and arrhythmia are the worst. In patients with arrhythmia, DM is associated with higher need for ICU, hypotension requiring vasopressor, and in-hospital mortality. A history of stroke/TIA and thrombocytopenia during admission are associated with higher need for intubation and MV.

Keywords : arrhythmia; coronavirus; COVID-19; hospitalization; adverse outcomes; mortality.

        · abstract in Spanish     · text in English     · English ( pdf )